What is the best way to treat COVID-19? Remdesivir and plasma are promising, but other drugs are needed.

This past week, Kalil and his colleagues finished enrolling more than 1,000 patients to test the effect of combining remdesivir, an antiviral, with a pill called baricitinib, an anti-inflammatory, used to treat rheumatoid arthritis. Preliminary findings from that phase of the study are expected within the month. While researchers work to analyze those results, they will simultaneously move forward with a separate round of studies, testing the impact of remdesivir plus another medication. NBC